23 items
2026-08-12
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the six month ending September 30, 2026 and fiscal year ending March 31, 2027. For the six month, the company expected net sales of JPY 34,500 million, operating profit of JPY 3,600 million, profit attributable to owners of parent of JPY 1,961 million and basic earnings per share of JPY 51.11. For the year, the company expected net sales of JPY 97,000 million, operating profit of JPY 16,000 million, profit attributable to owners of parent of JPY 11,100 million and basic earnings per share of JPY 289.21.
2026-07-24
Nomura Micro Science Co., Ltd., ¥ 30.0, Cash Dividend, Sep-29-2026
2026-07-15
Nomura Micro Science Co., Ltd., Board Meeting, Jul 15, 2026. Agenda: To consider and approve Regarding Issuance of Stock Options to our executive officers.
2026-06-24
Nomura Micro Science Co., Ltd. had informed that at the director meeting held on June 24, 2026, the company resolved to change the repayment date of the loan as follows regarding the 'Notice Regarding Changes to the Lending and Repayment Dates of Funds' dated February 13, 2026. In light of the cash flow situation of the group, the company will change the loan repayment date for the working capital of the large water treatment systems project secured by Nomura Micro Science USA Ltd. Co. Before change: Lender - Resona Bank, Limited, MUFG Bank, Ltd., Sumitomo Mitsui Banking Corporation; Borrowings amount - USD 200 million (maximum); Repayment due date - July 10, 2026; Interest rate - Benchmark interest rate+spread; Repayment method - Lump-sum repayment at maturity. After revision: Lender - Same; Borrowings amount - Same; Repayment due date - December 30, 2026; Interest rate - Same; Repayment method - Same. Before change: Lender - Resona Bank, Limited, MUFG Bank, Ltd., Sumitomo Mitsui Banking Corporation; Borrowings amount - USD 135 million; Repayment due date - July 10, 2026; Interest rate - Benchmark interest rate+spread; Repayment method - Lump-sum repayment at maturity. After revision: Lender - Same; Borrowings amount - Same; Repayment due date - December 30, 2026; Interest rate - Same; Repayment method - Same. The impact of this borrowing on the performance for Fiscal Year 2026 is minor.
2026-06-24
Nomura Micro Science Co., Ltd., Board Meeting, Jun 24, 2026. Agenda: To consider and approve Regarding Changes to the Lending and Repayment Dates of Funds.
2026-06-18
Nomura Micro Science Co., Ltd. reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 56,245.86 million compared to JPY 96,359.95 million a year ago. Net income was JPY 3,818.17 million compared to JPY 10,199.64 million a year ago. Basic earnings per share from continuing operations was JPY 100.36 compared to JPY 270.75 a year ago. Diluted earnings per share from continuing operations was JPY 98.42 compared to JPY 263.64 a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided dividend guidance for the second quarter-end of fiscal year ending March 31, 2027. For the period, the company expects dividend to be JPY 30.00 per share against JPY 20.00 per share paid a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided year-end dividend guidance for the fiscal year ending March 31, 2027. For the period, the company expects dividend to be JPY 55.00 per share against JPY 61.00 per share a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the six month ending September 30, 2026 and full year ending March 31, 2027. For the six month, the company expected net sales of JPY 34,500 million, operating profit of JPY 3,600 million, profit attributable to owners of parent of JPY 1,961 million and basic earnings per share of JPY 51.22. For the year, the company expected net sales of JPY 97,000 million, operating profit of JPY 16,000 million, profit attributable to owners of parent of JPY 11,100 million and basic earnings per share of JPY 289.90.
2026-05-20
Nomura Micro Science Co., Ltd., Board Meeting, May 20, 2026. Agenda: To consider the Notice regarding Dividends of Surplus.
2026-05-14
Nomura Micro Science Co., Ltd., Annual General Meeting, Jun 24, 2026.
2026-05-14
Nomura Micro Science Co., Ltd., 2026 Earnings Call, May 22, 2026
2026-05-09
Nomura Micro Science Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
2026-05-09
Nomura Micro Science Co., Ltd. announced that they will report Q1, 2027 results on Aug 07, 2026
2026-02-18
Nomura Micro Science Co., Ltd. reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 41,046.95 million compared to JPY 31,855.2 million a year ago. Net income was JPY 2,865.85 million compared to JPY 2,066.32 million a year ago. Basic earnings per share from continuing operations was JPY 75.43 compared to JPY 54.91 a year ago. Diluted earnings per share from continuing operations was JPY 74.01 compared to JPY 53.47 a year ago.
2026-02-14
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2026. For the year ending March 31, 2026, the company expects net sales of JPY 60,000 million, operating profit of JPY 6,200 million and profit attributable to owners of parent of JPY 3,837 million or JPY 100.90 per basic share.
2026-02-13
Nomura Micro Science Co., Ltd. expected to report Fiscal Year 2026 results on May 15, 2026. This event was calculated by S&P Global (Created on February 13, 2026).
2026-02-13
Nomura Micro Science Co., Ltd., Board Meeting, Feb 13, 2026. Agenda: To consider changing the repayment due date of the borrowed funds; and to consider other business matters.
2025-11-29
Nomura Micro Science Co., Ltd. announced dividend of JPY 20.00 per share for the second quarter ended September 30, 2025 compared to JPY 20.00 per share paid a year ago. Scheduled date to commence dividend payments: December 10, 2025.
2025-11-29
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2026. For the year ending March 31, 2026, the company expects net sales of JPY 60,000 million, operating profit of JPY 6,200 million and profit attributable to owners of parent of JPY 3,837 million or JPY 100.80 per basic share.
2025-11-16
Nomura Micro Science Co., Ltd., ¥ 50.0, Cash Dividend, Mar-30-2026
2025-11-14
Nomura Micro Science Co., Ltd., H1 2026 Earnings Call, Nov 17, 2025
2025-11-14
Nomura Micro Science Co., Ltd. revised consolidated earnings forecast for the fiscal year ending September 30, 2025. For the period, the company expects sales revenue of ¥25,193 million compared to previous of ¥24,500 million, operating profit of ¥2,861 million compared to previous of ¥2,115 million, interim net income attributable to parent company shareholders of ¥1,413 million compared to previous of ¥825 million, interim net income per share of ¥37.26 compared to previous of ¥21.78. Regarding the consolidated performance for Second Quarter (H1), sales revenue is expected to increase due to the faster-than-expected progress in water treatment systems projects in Japan and the US, while progress in similar projects in China and other regions has been delayed. In terms of profit, cost reductions in major water treatment systems projects in various locations have led to operating profit and other levels of profit exceeding the beginning of period forecasts. As for the full-year consolidated earnings forecast, there is a possibility of fluctuations in the timing and progress of some water treatment system orders, and careful assessment of these situations is necessary. Therefore, at present, the plan for the Fiscal Year ending March 2026, announced on May 15, 2025, will remain unchanged. If it is deemed necessary to revise the earnings forecast according to future circumstances, will announce it promptly.
2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 53,044 | 56,245 | 105,552 | 103,510 | 101,134 | 96,360 | 43,579 | 54,508 | 67,883 | 73,021 | 77,857 |
Pretax Income Excl.Unusual Items | 5,186 | 5,628 | 14,422 | 15,400 | 13,637 | 13,349 | 5,188 | 4,638 | 9,220 | 10,816 | 11,665 |
Total Assets | 111,078 | 110,290 | 109,712 | 103,959 | 103,874 | 116,783 | 100,351 | 88,415 | 79,742 | 70,603 | 60,671 |
Total Liabilities | 72,537 | 70,439 | 71,056 | 67,139 | 68,924 | 79,769 | 71,018 | 60,726 | 51,048 | 41,679 | 34,263 |
Cash & Cash Equivalents | 8,473 | 10,425 | 13,663 | 16,434 | 18,890 | 16,540 | 11,642 | 11,682 | 15,488 | 11,860 | 11,565 |
Total Common Equity | 38,541 | 39,851 | 38,656 | 36,820 | 34,950 | 37,014 | 29,333 | 27,689 | 28,694 | 28,924 | 26,408 |
Book Value Per Share (BVPS) | 1,003.91 | 1,040.8 | 1,013.68 | 967.24 | 923.02 | 977.57 | 777.51 | 734.33 | 764.24 | 773.95 | 705.87 |
Net Change in Cash | -6,606 | 4,235 | 4,680 | -10,399 | -1,356 | ||||||
Capital Expenditure | -1,378 | -808 | -2,104 | -2,009 | -344 |
On August 07, 2026, Nomura Micro Science shared its financial results for the second quarter of 2026, with revenues of 9.2B yen and net income of 239M yen, representing a sharp 25.8% drop in revenues, along with a significant decline of approximately 49.5% in EPS compared to the same quarter last year.
Moreover, the EBITDA margin decreased significantly from 14.45% to 11.42% in the comparable quarter previous year. A decline in operating profitability can signify a problem with sales or a rise in operating expenses, which could be detrimental to the stock's performance in the future. and it trades at 38.5x times current year's earnings, which is higher than the sector average (P/E 10.9x).